➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Johnson and Johnson
Moodys
Express Scripts
Mallinckrodt

Last Updated: November 23, 2020

DrugPatentWatch Database Preview

Litigation Details for Meijer Distribution, Inc. v. Allergan, Inc. (S.D.N.Y. 2016)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Meijer Distribution, Inc. v. Allergan, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Meijer Distribution, Inc. v. Allergan, Inc. (S.D.N.Y. 2016)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 on Delzicol is covered by U.S. Patent No. 6,649,180 (“the ’180 patent”), which expires April 13, 2020…the ’170 patent”) and 5,541,171 (“the ’171 patent”). Both patents expired July 30, 2013. 80. …would push Asacol (400mg) over the “patent cliff” – upon patent expiry in July 2013, Warner Chilcott …alleged infringement of that patent. Warner Chilcott’s listing of the capsule patent in the Orange Book, and…assertion that the patent claimed the drug product, was grossly improper: the patent claims only the capsules External link to document
0000-00-00 13 on Delzicol is covered by U.S. Patent No. 6,649,180 (“the ’180 patent”), which expires April 13, 2020…the ’170 patent”) and 5,541,171 (“the ’171 patent”). Both patents expired July 30, 2013. 80. …would push Asacol (400mg) over the “patent cliff” – upon patent expiry in July 2013, Warner Chilcott …alleged infringement of that patent. Warner Chilcott’s listing of the capsule patent in the Orange Book, and…assertion that the patent claimed the drug product, was grossly improper: the patent claims only the capsules External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
McKesson
Mallinckrodt
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.